SOLENO THERAPEUTICS INC
Develops novel therapeutics for rare diseases like Prader-Willi syndrome.
SLNO | US
Overview
Corporate Details
- ISIN(s):
- US8342033094
- LEI:
- Country:
- United States of America
- Address:
- 100 MARINE PARKWAY, SUITE 400, 94065 REDWOOD CITY
- Website:
- https://soleno.life/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is primarily dedicated to addressing complex and life-threatening genetic disorders with significant unmet medical needs. Its lead product candidate is DCCR (Diazoxide Choline), an extended-release tablet for the treatment of hyperphagia (unrelenting hunger) and other behavioral symptoms associated with Prader-Willi syndrome (PWS).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SOLENO THERAPEUTICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SOLENO THERAPEUTICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SOLENO THERAPEUTICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
